Lexology April 19, 2024
Sheppard Mullin Richter & Hampton LLP

This is the second post in a two-part series on PrivacyCon’s key-takeaways for healthcare organizations. The first post focused on healthcare privacy issues.[1] This post focuses on insights and considerations relating to the use of Artificial Intelligence (“AI”) in healthcare. In the AI segment of the event, the Federal Trade Commission (“FTC”) covered: (1) privacy themes; (2) considerations for Large Language Models (“LLMs”); and (3) AI functionality.

AI Privacy Themes

The first presentation within the segment highlighted a study involving more than 10,000 participants and gauged their concerns around the intersection of AI and privacy.[2] The study uncovered four privacy themes: (1) data is at risk (the potential for misuse); (2) data is highly personal (it can be used to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Govt Agencies, Healthcare System, Privacy / Security, Technology
OpenAI’s GPT-5 Model Reportedly Behind Schedule With Uncertain Future
10 AI Predictions For 2025
Three Practical Reasons To Consider AI Agents For Your Organization
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM
My Medical AI Holiday Wish List

Share This Article